Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Mipletamig by Aptevo Therapeutics for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
Mipletamig is under clinical development by Aptevo Therapeutics and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic...